Espinoza Gustavo, Castellanos Leonardo, Rodriguez-Una Ignacio, Camacho Paul Anthony, Parra Juan Camilo
Fundación Oftalmologica de Santander FOSCAL, Floridablanca, Santander, Colombia.
Instituto Oftalmologico Fernandez-Vega, University of Oviedo, Oviedo, Asturias 33012, Spain.
Int J Ophthalmol. 2018 Apr 18;11(4):635-640. doi: 10.18240/ijo.2018.04.16. eCollection 2018.
To assess the efficacy and safety of patterned laser trabeculoplasty (PLT) as an adjunctive treatment in open angle glaucoma (OAG) or ocular hypertension (OHT) patients who were under antiglaucoma medical treatment.
This study was a retrospective review of primary or secondary OAG patients and OHT patients with medically uncontrolled (≥18 mm Hg) intraocular pressure (IOP) who underwent 360° PLT from June 2016 to August 2016. Follow-up visits at week 1, and 1, 3 and 6mo were performed. IOP, best corrected visual acuity (BCVA), complications and eye drop glaucoma medication were recorded at each follow-up visit. Success was defined as IOP reduction ≥20% from baseline.
Forty-one eyes of 25 patients were included in this study. Pre-treatment mean IOP was 20.2±1.6 mm Hg. After PLT, IOP was 19.3±5.2, 16.1±2.7, 17.1±3.7 and 16.3±3.5 mm Hg, at 1wk, 1, 3 and 6mo, respectively. IOP reduction from baseline was statistically significant from the first month, remaining stable at 6mo (<0.001). PLT success at 6mo of follow-up was 48.78%. The number of glaucoma medication per eye (=0.10) and the mean BCVA both remained constant (=0.37). Complications included transient IOP spikes in 4 eyes (9.8%) and peripheral anterior synechiae in 7 eyes (17.1%).
PLT is an effective and safe method for the management of patients with OHT or OAG as an adjunctive therapy. Additional larger studies should be designed to verify the long-term stability of IOP reduction with this laser technology.
评估在接受抗青光眼药物治疗的开角型青光眼(OAG)或高眼压症(OHT)患者中,作为辅助治疗的选择性激光小梁成形术(PLT)的疗效和安全性。
本研究是对2016年6月至2016年8月接受360°PLT治疗的原发性或继发性OAG患者以及药物治疗不能控制(≥18 mmHg)眼压(IOP)的OHT患者进行的回顾性研究。在第1周、1、3和6个月进行随访。每次随访时记录IOP、最佳矫正视力(BCVA)、并发症和青光眼滴眼液用药情况。成功定义为IOP较基线降低≥20%。
本研究纳入了25例患者的41只眼。治疗前平均IOP为20.2±1.6 mmHg。PLT后,在第1周、1、3和6个月时,IOP分别为19.3±5.2、16.1±2.7、17.1±3.7和16.3±3.5 mmHg。从第一个月起,IOP较基线的降低具有统计学意义,在6个月时保持稳定(<0.001)。随访6个月时PLT成功率为48.78%。每只眼青光眼用药数量(=0.10)和平均BCVA均保持不变(=0.37)。并发症包括4只眼(9.8%)出现短暂IOP峰值和7只眼(17.1%)出现周边前粘连。
PLT作为辅助治疗是管理OHT或OAG患者的一种有效且安全的方法。应设计更多大型研究来验证这种激光技术降低IOP的长期稳定性。